Screening for Depression Does Not Improve Outcomes, Even with Targeted Feedback
A study involving over 8,000 patients challenges the effectiveness of depression screening in primary care settings.
Stay updated with breaking news from Eppendorf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study involving over 8,000 patients challenges the effectiveness of depression screening in primary care settings.
No improvement seen in insulin resistance nor in diurnal blood pressure, melatonin, cortisol profiles
Two patients were treated with KYV-101, a fully human anti-CD19 CAR T-cell product candidate, in Germany as part of a named patient program after failure to respond to conventional therapies The...
/PRNewswire/ -- Cell Culture Market in terms of revenue was estimated to be worth $30.9 billion in 2024 and is poised to reach $57.9 billion by 2029, growing...
Attacq Limited welcomes Eppendorf, a global life science leader, to Waterfall City's ecosystem, alongside other prestigious brands...